Ami R Zota1, Ruth J Geller2, Laura E Romano2, Kimberly Coleman-Phox3, Nancy E Adler4, Emily Parry5, Miaomiao Wang5, June-Soo Park5, Angelo F Elmi2, Barbara A Laraia6, Elissa S Epel4. 1. Milken Institute School of Public Health, The George Washington University, Washington, DC, USA. Electronic address: azota@gwu.edu. 2. Milken Institute School of Public Health, The George Washington University, Washington, DC, USA. 3. Center for Health and Community, School of Medicine, University of California, San Francisco, CA, USA. 4. Department of Psychiatry, School of Medicine, University of California, San Francisco, CA, USA. 5. Environmental Chemistry Laboratory, California Department of Toxic Substances Control, Berkeley, CA, USA. 6. Division of Community Health and Human Development, School of Public Health, University of California, Berkeley, CA, USA.
Abstract
BACKGROUND: Endocrine-disrupting chemicals (EDCs) can target immune and metabolic pathways. However, few epidemiologic studies have examined the influence of EDCs on measures of inflammation and cellular aging during pregnancy and postpartum. OBJECTIVE: We investigated associations between prenatal exposures to polybrominated diphenyl ethers (PBDEs), hydroxylated PBDE metabolites (OH-PBDEs), polychlorinated biphenyls (PCBs), and per- and polyfluorochemicals (PFASs) with repeated biomarker measurements of inflammation and cellular aging in women during pregnancy and the postpartum period. METHODOLOGY: Overweight or obese pregnant women were recruited from the San Francisco Bay area (n = 103) during their first or second trimester of pregnancy. Blood samples were collected from participants at baseline (median 16 weeks gestation) and at three and nine months postpartum. Serum concentrations of PBDEs, OH-PBDEs, PCBs, and PFASs were measured at baseline. Inflammation biomarkers (interleukin 6 [IL-6], interleukin 10 [IL-10], and tumor necrosis factor [TNF-α]) and leukocyte telomere length (LTL), a biomarker of cellular aging, were measured at all three time points. Associations between serum chemical concentrations and repeated measures of IL-6, IL-10, TNF-α, and LTL were examined using linear mixed models. We also examined the potential for effect modification by time (visit) and obesity. RESULTS: In adjusted models, we observed positive relationships between PBDEs and pro-inflammatory cytokines (IL-6 and TNF-α). A doubling in ∑PBDEs was associated with a 15.26% (95% CI 1.24, 31.22) and 3.74% (95% CI -0.19, 7.82) increase in IL-6 and TNF-α, respectively. Positive associations were also observed for PFASs and IL-6. A two-fold increase in ∑PFASs was associated with a 20.87% (95% CI 3.46, 41.22) increase in IL-6. 5-OHBDE-47 was inversely associated with anti-inflammatory cytokine IL-10. Some EDC-outcome associations, including those of PBDEs with TNF-α, were stronger during pregnancy (compared to three or nine months postpartum) and among obese (compared to overweight) women (p-interaction <0.05). CONCLUSIONS: These findings suggest that exposure to specific EDCs is associated with increased inflammation among women during pregnancy and the postpartum period. Future studies should replicate these findings in additional study populations and examine the implications of these associations for maternal and child health.
BACKGROUND: Endocrine-disrupting chemicals (EDCs) can target immune and metabolic pathways. However, few epidemiologic studies have examined the influence of EDCs on measures of inflammation and cellular aging during pregnancy and postpartum. OBJECTIVE: We investigated associations between prenatal exposures to polybrominated diphenyl ethers (PBDEs), hydroxylated PBDE metabolites (OH-PBDEs), polychlorinated biphenyls (PCBs), and per- and polyfluorochemicals (PFASs) with repeated biomarker measurements of inflammation and cellular aging in women during pregnancy and the postpartum period. METHODOLOGY: Overweight or obese pregnant women were recruited from the San Francisco Bay area (n = 103) during their first or second trimester of pregnancy. Blood samples were collected from participants at baseline (median 16 weeks gestation) and at three and nine months postpartum. Serum concentrations of PBDEs, OH-PBDEs, PCBs, and PFASs were measured at baseline. Inflammation biomarkers (interleukin 6 [IL-6], interleukin 10 [IL-10], and tumor necrosis factor [TNF-α]) and leukocyte telomere length (LTL), a biomarker of cellular aging, were measured at all three time points. Associations between serum chemical concentrations and repeated measures of IL-6, IL-10, TNF-α, and LTL were examined using linear mixed models. We also examined the potential for effect modification by time (visit) and obesity. RESULTS: In adjusted models, we observed positive relationships between PBDEs and pro-inflammatory cytokines (IL-6 and TNF-α). A doubling in ∑PBDEs was associated with a 15.26% (95% CI 1.24, 31.22) and 3.74% (95% CI -0.19, 7.82) increase in IL-6 and TNF-α, respectively. Positive associations were also observed for PFASs and IL-6. A two-fold increase in ∑PFASs was associated with a 20.87% (95% CI 3.46, 41.22) increase in IL-6. 5-OHBDE-47 was inversely associated with anti-inflammatory cytokine IL-10. Some EDC-outcome associations, including those of PBDEs with TNF-α, were stronger during pregnancy (compared to three or nine months postpartum) and among obese (compared to overweight) women (p-interaction <0.05). CONCLUSIONS: These findings suggest that exposure to specific EDCs is associated with increased inflammation among women during pregnancy and the postpartum period. Future studies should replicate these findings in additional study populations and examine the implications of these associations for maternal and child health.
Authors: Jamie C DeWitt; Alexander Shnyra; Mostafa Z Badr; Scott E Loveless; Denise Hoban; Steven R Frame; Robyn Cunard; Stacey E Anderson; B Jean Meade; Margie M Peden-Adams; Robert W Luebke; Michael I Luster Journal: Crit Rev Toxicol Date: 2009 Impact factor: 5.635
Authors: Hongling Liu; Song Tang; Xinmei Zheng; Yuting Zhu; Zhiyuan Ma; Chunsheng Liu; Markus Hecker; David M V Saunders; John P Giesy; Xiaowei Zhang; Hongxia Yu Journal: Environ Sci Technol Date: 2015-01-21 Impact factor: 9.028
Authors: D L Phillips; J L Pirkle; V W Burse; J T Bernert; L O Henderson; L L Needham Journal: Arch Environ Contam Toxicol Date: 1989 Jul-Aug Impact factor: 2.804
Authors: Mandy Fisher; Tye E Arbuckle; Chun Lei Liang; Alain LeBlanc; Eric Gaudreau; Warren G Foster; Douglas Haines; Karelyn Davis; William D Fraser Journal: Environ Health Date: 2016-05-04 Impact factor: 5.984
Authors: Suril S Mehta; Tamarra James-Todd; Katie M Applebaum; Andrea Bellavia; Kimberly Coleman-Phox; Nancy Adler; Barbara Laraia; Elissa Epel; Emily Parry; Miaomiao Wang; June-Soo Park; Ami R Zota Journal: Environ Res Date: 2020-12-02 Impact factor: 6.498
Authors: Abigail Erinc; Melinda B Davis; Vasantha Padmanabhan; Elizabeth Langen; Jaclyn M Goodrich Journal: Environ Res Date: 2021-04-03 Impact factor: 8.431
Authors: Susanna D Mitro; Sharon K Sagiv; Abby F Fleisch; Lindsay M Jaacks; Paige L Williams; Sheryl L Rifas-Shiman; Antonia M Calafat; Marie-France Hivert; Emily Oken; Tamarra M James-Todd Journal: J Clin Endocrinol Metab Date: 2020-09-01 Impact factor: 5.958